Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga December 22, 2014 at 08:18 AM EST Gilead Sciences Inc. (NASDAQ: GILD) shares dropped 9.73% to $97.90 in pre-market trading. Gilead Sciences and Ono Pharma reported that ... Read More >> Related Stocks: Barrick Gold Corp Biogen Idec Gilead Sciences Vertex Pharmaceuticals